|
|
Volumn 163, Issue 1, 2002, Pages 1-3
|
|
Commentary on "Clinical studies on the mechanism of action of clozapine; the dopamine-serotonin hypothesis of schizophrenia." Psychopharmacology (1989) 99:S18-S27
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
(3 CHLOROPHENYL)PIPERAZINE;
2,3,3A,12B TETRAHYDRO 3 METHYL 1H DIBENZO[B,F]OXEPINO[10,11 C]PYRROLE;
5 HYDROXYINDOLEACETIC ACID;
5 HYDROXYTRYPTOPHAN;
6 CHLORO 2 (1 PIPERAZINYL)PYRAZINE;
APOMORPHINE;
BIONANSERIN;
CHLORPROMAZINE;
CLOZAPINE;
DOPAMINE;
DOPAMINE 1 RECEPTOR;
DOPAMINE 2 RECEPTOR;
HALOPERIDOL;
HOMOVANILLIC ACID;
ILOPERIDONE;
JL 13;
NEUROLEPTIC AGENT;
OLANZAPINE;
PERISPERONE;
QUETIAPINE;
RISPERIDONE;
SEROTONIN;
SEROTONIN 1A RECEPTOR;
SEROTONIN 2A RECEPTOR;
SEROTONIN 2C RECEPTOR;
TRYPTOPHAN;
UNCLASSIFIED DRUG;
ZIPRASIDONE;
AGRANULOCYTOSIS;
APPETITE;
AROUSAL;
COGNITION;
COMPUTER ASSISTED EMISSION TOMOGRAPHY;
DOPAMINERGIC SYSTEM;
DRUG EFFICACY;
DRUG INHIBITION;
DRUG MECHANISM;
DRUG RECEPTOR BINDING;
DRUG SAFETY;
DRUG TOLERABILITY;
EXTRAPYRAMIDAL SYMPTOM;
FOOD AND DRUG ADMINISTRATION;
HUMAN;
HYPOTHESIS;
LIMBIC CORTEX;
MOOD;
NERVE CELL;
NEUROTRANSMISSION;
NIGRONEOSTRIATAL SYSTEM;
NONHUMAN;
NOTE;
PRIORITY JOURNAL;
PROLACTIN RELEASE;
PSYCHOPHARMACOLOGY;
RECEPTOR AFFINITY;
RECEPTOR BLOCKING;
SCHIZOPHRENIA;
SEROTONINERGIC SYSTEM;
ANTIPSYCHOTIC AGENTS;
CLOZAPINE;
DOPAMINE;
HUMANS;
SCHIZOPHRENIA;
SEROTONIN;
|
|
EID: 0036365725
PISSN: 00333158
EISSN: None
Source Type: Journal
DOI: 10.1007/s00213-002-1088-0 Document Type: Note |
|
Times cited : (8)
|
|
References (15)
|
